How Generative Artificial Intelligence is Transforming the Brazilian Health Sector

Implementation of generative AI in the health sector, in accordance with ANVISA regulations.

Discover how the adoption of generative AI is driving productivity and reinvention for healthcare companies in Brazil. Generative Artificial Intelligence (AI) is becoming a crucial tool for the healthcare sector in Brazil, bringing productivity and efficiency gains to companies. According to the 28th edition of the Global CEO Survey, 58% of healthcare CEOs in Brazil […]

The Trends of the Health Sector in Brazil and the Impact of Technological Innovation

Executives analyzing innovation trends in health and regulation by ANVISA.

How Technological Innovation and Generative AI Are Transforming the Healthcare Market in Brazil The 28th Global CEO Survey revealed that business leaders are increasingly focused on reinventing their business models to generate value, ensure sustainability and drive innovation. In the healthcare sector in Brazil, this trend translates into the accelerated adoption of generative artificial intelligence, […]

RDC 954/2024: Updates to the Simplified Drug Registration Procedure

Experts discuss RDC 954/2024 and its impact on drug registration in Brazil.

Key Changes and Impacts for Drug Manufacturers The recent update of RDC 954/2024 brought significant changes to the simplified procedure for registering medicines in Brazil. In an exclusive event held by ANVISA on March 13, experts discussed the main guidelines and their impacts on the pharmaceutical sector. QR Group has closely followed the news to […]

Anvisa Resumes Monitoring of Medical Device Prices: What Does This Mean for the Sector?

ANVISA update on monitoring medical device prices.

Transparency and Regulation: QR Group Explains the Resumption of Data Publication Anvisa has resumed the publication of medical device price monitoring data on its Business Intelligence (BI) dashboards. This activity, previously suspended due to the Agency’s internal restructuring, once again offers crucial information for the health sector. With this resumption, companies in the segment have […]

Why is Good Manufacturing Practices Training Essential in Brazil?

QR Group offers good manufacturing practices training solutions to ensure ANVISA compliance and quality in Brazil.

QR Group Explains How Training Can Be a Competitive Advantage in the Healthcare Market In Brazil, where the healthcare sector is constantly evolving, companies that invest in good manufacturing practices stand out for the quality and safety of their products. QR Group, a specialist in regulatory consulting and product registration with ANVISA, reinforces the importance […]